saascode
fintech & payments·run 27 · Apr 2026

Allokey

An educational research workbook that normalizes source-linked fields from authorized small-business investment offerings, exposes missing definitions and liquidity limits, and lets users apply their own neutral filters without ranking, recommending or enabling transactions.

Genesis score5.77/10
Make Allokey real.0/500
500 more votes and Allokey is authorized for build.
0%500 to authorize
Backing is the vote. When an idea crosses 500, we pull it into the build pipeline and ship it for real — the votes decide what gets built next, not an editor.
The opportunity
3Confirmed small-business investment platforms
0Confirmed public developer interfaces
0Reviewed cross-platform normalizers found
The case

The research confirms three small-business investment platforms and found no reviewed cross-platform pre-screening and metric-normalization layer. None of the reviewed platforms exposes a public developer interface, making partnerships or other explicitly authorized data access a pre-build gate. One proposed anchor is early and may not persist, so the catalog cannot depend on a single venue.

Allokey should separate issuer assertion, platform disclosure, source document, metric definition, normalization candidate, missing data, uncertainty, comparison view, user-defined factual filter, educational note, qualified diligence, suitability or investment advice obtained elsewhere, user decision, external transaction and outcome. Sparse private-company disclosures cannot support a universal risk or reversibility score.

The product must not recommend, rank, predict returns, label an investment safe, determine suitability, personalize opportunities from sensitive or financial traits, scrape without permission, handle orders or funds, or imply liquidity. Revenue-share and other small-business interests may be illiquid, speculative and difficult to compare.

Who pays — and why

Self-directed adults researching small-business investment offerings who want source-linked comparisons before seeking qualified advice or acting on an authorized platform.

What it unlocks
A platform and rights register with venue, offering type, jurisdiction, access method, partnership or license, terms, disclosure documents, update cadence, owner, validation date and status
An offering evidence file with issuer, legal entity, security or contract type, target, term, payment formula, fees, priority, collateral assertion, use of proceeds, financial period, source, date, corrections and expiry
A metric worksheet separating native definition, numerator and denominator, period, currency, accounting basis, normalization candidate, incompatibility, missing data, uncertainty, issuer or platform correction and reviewer note
A user research record with self-defined factual filters, saved comparisons, educational explanations, risk and liquidity questions, qualified-advice reminder, external platform link, no transaction state, correction and deletion
How Genesis scored it
5.77across seven criteria
tension 6temporal 5blindspot 5buyer 7leverage 7convergence 5why-not 5
7
Buyer persona

Self-directed investors are identifiable, though budget and current alternative need validation.

7
Asymmetric leverage

Normalization can scale, but licensed data and qualified review constrain it.

5
Why nobody did it

The record does not prove which barrier recently changed.

Why it scored well

A clear self-directed research buyer, multiple confirmed venues and an absent comparison layer make evidence normalization understandable.

What's holding it back

No public interfaces or recent trigger are established; securities regulation, data rights, sparse disclosures, metric comparability, liability and platform dependence are material.

Signals detected3 sources crossed
SignalGenesis research

SignalGenesis research

SignalGenesis research

Direction briefallokey.md
allokey.md
Want this pointed at your vertical?Point Genesis at your own market and constraints — it invents adjacent, fork-ready ideas, private to you before they hit the public feed.

Discussion

?

No comments yet — be the first to weigh in.